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ABSTRACT
Chronic lymphocytic leukemia (CLL) is a lymphoid neoplasia with the B immunophenotype, which corresponds to the 
leukemic form of lymphocytic lymphoma. This entity is characterized, in most cases, by immunosuppression due to 
impaired function of immune cells, hypogammaglobulinemia, bone marrow infiltration, and immune dysfunction due 
to the neoplasia and the chemotherapy, when prescribed. We describe the case of a 63-year-old woman with a previous 
diagnosis of advanced CLL, refractory to treatment, who presented respiratory failure at the emergency department and 
died soon after hospital admission. The autopsy examination showed a large retroperitoneal mass compressing large 
vessels and abdominal and pelvic organs; generalized lymphadenopathy; and liver, spleen, bone marrow, heart and 
kidney infiltration. A Gram-negative bacilli bronchopneumonia with diffuse alveolar damage was detected, which was 
likely to be the immediate cause of death. 
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CASE REPORT
A 63-yea r -o ld  Caucas i an  woman,  who 
was previously diagnosed with type-2 diabetes, 
hypertension, and hypothyroidism, presented a 2-year 
history of weight loss (nearly 20 kg) intermittent fever, 
nocturnal sweating, progressive abdominal distension, 
and generalized lymphadenopathy. Her first complete 
blood count showed a hemoglobin of 8.0 g/dL 
(reference value [RV]: 12.3-15.5 g/dL), neutrophils of 
3.510/mm3 (RV: 4.4-11.3 × 103/mm3), lymphocytes of 
112,320/mm3 (RV: 1.2-4.0 × 103/mm3, and platelets 
of 83,000/mm3 (RV:150-400 × 103/mm3). The flow 
cytometric immunophenotyping of the peripheral 
blood, bone marrow aspirate, and a needle biopsy on 
the right axillary lymph node rendered the diagnosis 
of chronic lymphoid leukemia (CLL)/lymphocitic 
lymphoma. The bone marrow aspirate showed more 
than 90% of mature lymphocytes CD20-positive, 
CD5-positive, CD10-negative, and immunoglobulin 
M ( IgM)-negative. The lymph node histology 
showed complete replacement of the lymph node 
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architecture by small lymphoid cells (Figure 1A). 
The immunohistochemistry was positive for CD-20 
(Cell Marque™ L26), CD-23 (Cell Marque™ 1B12), 
and CD-5 (Cell Marque™ 4C7); and negative for CD-3 
(Cell Marque™ MRQ-39), cyclin-D1 (Spring™ SP4), 
and CD-10 (Cell Marque™ 56C6) (Figure 1B, D). 
Zeta-chain-associated protein kinase-70 (ZAP-70) 
(Ventana™ 2F3.2) was positive (Figure 2) and p53 
(Cell Marque™ DO7) was negative. Anti- LEF-1 was 
not available. The Ki-67 (Spring™ SP6) showed a low 
index of positivity (Figure 1E). The bone marrow biopsy 
was hypercellular due to CLL interstitial infiltration. 
The peripheral blood karyotypes test was positive for 
trisomy 12. The positron emission tomography was 
not consistent with signs of high-grade non-Hodgkin’s 
lymphoma transformation. The clinical evaluation 
set the disease as an advanced stage (Rai stage IV 
and Binnet stage C with a bulky abdominal mass 
measuring more than 10.0 cm and the presence of 
“B symptoms”). A transthoracic echocardiogram 
showed concentric left ventricle hypertrophy, with an 
ejection fraction of 63%.
The patient received four cycles of fludarabine-based 
chemotherapy associated with cyclophosphamide and 
dexamethasone. Unfortunately, the rituximab was 
not available. The patient developed pneumonia 
and episodes of febrile neutropenia. A discrete renal 
dysfunction was detected, which was probably due to 
infection; however, normal renal function was restored 
Figure 1. Photomicrography of the lymph node showing typical histology and immunophenotype of a chronic 
lymphoid leukemia diagnosis. A - Lymph node obliterated by small and mature lymphoid cells (H&E, 100X); B - CD20 
membranous positivity (IH-Cell Marque™ L26 clone, 200X); C - CD23 positivity (IH-Cell Marque™ 1B12, 200X); 
D - CD5 aberrant positivity (IH-Cell Marque™ 4C7 clone, 200X); E - Ki67 low index positivity (IH-Cell Marque™ SP6 
clone, 200X).
Autopsy and Case Reports 2016;6(1):11-20
Amaral FGC, Lima LGCA, Hatanaka VMA, Siqueira SAC, Duarte-Neto AN
13
after fluid replacement. After 3 months of treatment, 
the patient was brought to the emergency facility 
with respiratory failure, signs of circulatory shock, 
and altered mental status. According to her family, 
she had recently complained of dyspnea and a cough 
with bloody sputum, which worsened on the way 
to the hospital. On admission she presented cardiac 
arrest, which did not respond to advanced cardiac life 
support maneuvers. During orotracheal intubation, a 
large amount of frothy bloody secretion was drained 
from the airways. The autopsy was performed.
AUTOPSY FINDINGS
The corpse weighted 46.0 kg and measured 
149.0 cm in length (body mass index 20.72). During 
the external examination, an abdominal bulging on 
the left side was noticed.
At the opening of thoracic cavity, the lungs 
were heavy and hardened showing pleuropulmonary 
adhes ions.  The r ight  lung weighed 554.0 g 
(mean [m] RV: 465 g) and the left lung: 702.0g 
(mRV: 400 g). At the cut surface, a moderate 
amount of foamy and serohemorrhagic f luid 
drained after parenchymal compression. Acute 
bronchopneumonia and histological signs of diffuse 
alveolar damage, represented by the formation 
of hyaline membrane, septal necrosis, and foci 
of pulmonary hemorrhage, were disclosed at 
microscopy. Septal vessels had fibrinoid necrosis and 
mild bronchiolar inflammation. Gram-negative bacilli 
(Brown-Hopps staining), permeating the bronchi wall 
as well as the small septal vessels, extending into the 
adjacent pulmonary parenchyma, were found. Septal 
congestion, recent alveolar edema, and siderophages 
(hemosiderin-containing macrophages) within alveolar 
spaces were other evident features (Figure 3).
The heart weighted 260.0 g (mRV: 260 g); the 
coronary arteries were tortuous and obstructions 
did not exceed 40%; mild/moderate calcification 
of the aortic valve was observed. Microscopically, 
cardiomyocyte hypertrophy and rounded foci of small 
lymphocytes in the epicardial fat layer compatible with 
CLL infiltration (Figure 4) were observed.
At the opening of the peritoneal cavity, a bulging, 
lobulated, and well-defined retroperitoneal mass 
measuring 24.0 × 20.0 × 13.0 cm and weighing 3076.0 g 
was found, which compressed the large vessels, and the 
abdominal and pelvic viscera (Figure 5A, B). Generalized 
lymphadenopathy (para-aortic, paracaval, mesenteric, 
mesocolic, hepatic hilum, splenic hilum, peripancreatic, 
iliac, mediastinal, bilateral cervical, supraclavicular, 
axillary, and inguinal) was observed, with lymph nodes 
measuring from 2.0 to 10.0 cm at their longest axis. 
At the cut surface, the retroperitoneal mass and the 
lymph nodes were light-brown, bright, homogeneous, 
and fleshy, with firm-elastic consistency on palpation 
(Figure 5C). Microscopic examination revealed diffuse 
proliferation of small lymphocytes, without necrosis or 
mitotic figures, alternating with some vaguely nodular 
areas composed by slightly larger cells (Figure 5D, E).
The bone marrow sampled from the iliac crest 
was infiltrated by small lymphocytes representing more 
than 90% of marrow cellular tissue (Figure 6A, B). 
The spleen had a marked expansion of the white pulp 
due to atypical lymphoid cells (Figure 6C, D).
The liver had a sinusoidal dilatation around the 
central vein, while the portal tracts were extensively 
infiltrated by atypical lymphocytes, which were 
morphologically similar to those described in the lymph 
nodes (Figure 7A, B).
The aorta and i ts  branches had mult iple 
atherosclerotic plaques, some of them ulcerated, 
including the ostia of the renal arteries. The kidney 
volumes were mildly increased (right kidney weighed 
164.0 g; left kidney 158.0 g [RV of both: 288 g]) 
Figure 2. Photomicrography of the lymph node 
showing partial cytoplasmic positivity for ZAP-70 of 
the neoplastic cells with moderate or strong intensity 
(Immunohistochemistry-Ventana™ 2F3.2, 600X).
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Figure 3. Photomicrographs of the lungs showing acute lung damage due to Gram-negative bacilli pneumonia: 
A - Septal congestion, alveolar edema, and foci of hemorrhage (H&E, 50X); B - Foci of hemorrhage and septal 
alveolar necrosis with cellular debris. Note the inflammatory reaction is not exuberant (H&E, 50X); C - Congestion 
and organizing pneumonia (H&E, 50X); D - Gram-negative bacilli (arrow) within the lumen and permeating the wall 
of anthracotic bronchi, indicating the airways as the route of acquisition of the pneumonia. The ciliated columnar 
epithelium was slaughtered (Brown-Hopps stain, 400X).
Figure 4. Photomicrography of the heart: A and B - A nodular lymphoid infiltrate in the epicardial fat composed of 
small lymphocytes compatible with CLL infiltration (H&E: A 20X; B 200X); C - Cardiomyocyte hypertrophy containing 
lipofuscin pigment (H&E, 200X).
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exhibiting a focus of CLL infiltration, nephrosclerosis, 
and acute tubular necrosis (Figure 7C, D). There was no 
evidence of high-grade transformation or association 
with Hodgkin’s lymphoma in any of the organs 
examined after extensive sampling. The remaining 
organs and structures did not show unusual histological 
features.
The findings of the autopsy point towards the 
septic shock and acute respiratory failure due to 
Gram-negative pneumonia and diffuse alveolar damage 
as the immediate cause of death in a patient with 
advanced CLL. The pulmonary edema observed was 
likely caused by a synergistic pathogenic mechanism, 
involving the infection and left ventricular diastolic 
dysfunction due to chronic arterial hypertension.
DISCUSSION
The case reported herein describes a woman who 
died of a leukemized and refractory non-Hodgkin’s 
lymphoma. The CLL is a B-immunophenotype lymphoid 
neoplasia that represents the leukemic form of 
lymphocytic lymphoma.1,2 CLL corresponds to 5-10% 
of non-Hodgkin’s lymphomas. 90% of CLL, in the 
United States and Europe, affects patients older than 
50 years (usually between 55 and 65 years of age) and 
is twice as common in men. It is the most common 
form of leukemia in adults.2-5
The criteria used for differentiating lymphoma 
and leukemia is based on the number of circulating 
lymphocytes in the peripheral blood. Thus, when 
Figure 5. Gross finding of the retroperitoneal mass. A, B and C - The mass was formed by a conglomerate of lymph 
nodes, measuring up to 24.0 × 20.0 × 13.0 cm (C, after fixation in formalin 10%); D - Photomicrography of the 
abdominal mass showing the obliteration of lymph nodes by small lymphocytes, in a similar pattern to the biopsy at 
Figure 1 (H&E, 50X); E - Histologic detail of the neoplasia formed by small mature lymphocytes without large cells 
(H&E, 400X).
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the monoclonal lymphocytes count is greater 
than 5000 cells/mm3, the leukemia diagnosis is 
established. In these cases, the histological and 
immunohistochemical methods are not essential for this 
purpose.1,2 CLL is characterized by an indolent-course 
generalized lymphadenopathy. When the lymphocytic 
lymphoma becomes leukemic, extra-nodal involvement 
becomes more frequent. Over 90% of patients present 
advanced-stage disease (stage III and IV) at the time of 
diagnosis, with bone marrow involvement in 70-80% 
of the cases, and liver and/or spleen infiltration in 
25–55% of cases.6,7 The “B symptoms” (weight 
loss, fever, and night sweats) occur in up to 10% of 
the cases.1 Hemolytic anemia, thrombocytopenia, 
and other autoimmune phenomena are observed in 
fewer than one-third of cases.8 Immune dysfunction 
leading to immunosuppression is described in a 
relatively high proportion of cases, even when 
there is no bone marrow failure. Some authors8,9 
consider the CLL immunosuppression arising from 
the dysfunction of T-cells, NK-cells, neutrophils, and 
macrophages stemming from the deregulation in 
interleukin production (IL-6 and IL-10), the tendency 
to Th2 polarization of the immune response, the 
cell-to-cell interactions, and the direct cytotoxicity. 
Hypogammaglobulinemia is described in up to 40% 
of CLL cases and contributes to the vulnerability 
to infection.8 The majority of infections are due to 
Figure 6. Photomicrographs of the bone marrow and the spleen infiltrated by chronic lymphoid leukemia (CLL). 
A - Interstitial and nodular patterns of CLL infiltration, replacing almost the entire marrow space (H&E, 10X); B - Detail 
of the nodule in the marrow space formed by small lymphocytes (H&E, 400X); C - Expansion of the splenic white 
pulp due to small mature lymphocytes (H&E, 10X); D - A detail of the splenic central artery surrounded by small 
mature lymphocytes (H&E, 200X).
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bacteria (Streptococcus pneumoniae, Staphylococcus 
aureus, Haemophillus influenza, and Gram-negative 
bacilli) causing a lower respiratory tract infection, 
followed by viruses (Herpes simplex, Herpes zoster). 
The immunosuppressive drugs used for the treatment 
may also predispose the patient to opportunistic 
infections caused by fungi, protozoa, bacteria (Listeria 
monocytogenes), and virus (cytomegalovirus). The risk 
of infection increases over time and is usually the 
cause of death.8 Batlle et al.10 reported 30 episodes 
of pneumonia in CLL with etiological confirmation 
in 53% of the episodes of pneumonia in a series 
comprising 17 patients. The most common agent was 
Pneumococcus (five cases) followed by Pseudomonas 
aeruginosa (four cases), Pneumocystis jirovecii 
Figure 7. Liver and renal involvement in chronic lymphoid leukemia. A - photomicrography of the liver showing 
expanded portal tracts due to infiltrative small mature lymphocytes (H&E, 20X); B - Photomicrography showing a 
detail of the portal tract infiltrated by small mature lymphocytes (H&E, 200X); C - Gross appearance of the kidneys 
showing bilateral dilated renal pelvis due to ureteral compression by enlarged lymph nodes (kidneys fixed with 
formalin 10%); D - Photomicrography showing interstitial neoplastic infiltration of the renal parenchyma (H&E, 
50X).
(two cases) and Aspergillus fumigatus (two cases). 
Of note, the pneumonia caused by opportunistic 
agents was associated with fludarabine and three out 
of four cases of P. aeruginosa pneumonia died (75%).
The clinical course of CLL is usually indolent and 
generally asymptomatic with deaths not related to the 
neoplasia. However, some patients may present a rapid 
course, dying in 2 or 3 years after the diagnosis due to 
treatment refractoriness and complications (infections, 
hemorrhage, and cachexia). CLL is considered an 
incurable disease with an overall median survival of 
7 years.1,2
The histology of the lymph nodes in CLL presents, 
in general, the complete replacement of the nodal 
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architecture by a diffuse proliferation of small round 
lymphocytes (6-12 microns), which may enfold some 
residual germinal centers (mimicking a marginal 
zone lymphoma) extending to the capsule and 
adjacent adipose tissue.2 In addition, there are larger 
cells with loose chromatin, called pro-lymphocytes 
(medium-sized cells with small eccentric nucleoli), and 
para-immunoblasts (the largest cells in the neoplasia 
with a central and large nucleoli).2 These larger 
cells are found isolated or in a small grouping – the 
pseudofollicles – which are more frequent in lymph 
nodes than extranodal sites and have an increased 
proliferative index. The disease has an accelerated 
course and a poorer prognosis when a predominance 
of prolymphocytes and/or para-immunoblasts in 
peripheral blood is present.2,11 Other less common 
histological patterns may be found; namely, the presence 
of Reed-Sternberg-like CD30-positive; Epstein-Barr 
virus-infected cells; plasma cell differentiation with IgM 
overproduction (5% of the cases); Richter’s syndrome, 
which represents the transformation to diffuse large 
B cell lymphoma (5-20% of the cases); and Hodgkin’s 
lymphoma (0.5-2% of the cases).2 The bone marrow 
involvement may be nodular, interstitial, and/or diffuse. 
The diffuse pattern is characterized by the complete 
replacement of the bone marrow by the leukemic cells 
and is associated with advanced disease, as observed 
in our case.2
In this case, the involvement of the kidney and 
the heart was mild. It is not an infrequent finding in 
CLL, especially in advanced disease, but it is usually 
asymptomatic in both.12-15 Kidney infiltration is bilateral 
and involves both the cortex and the medulla.15 
Acute renal failure is extremely rare, being described 
in about 25 autopsy cases,16-18 all having massive 
CLL kidney infiltration.16 Heart involvement can be 
endocardial, myocardial, and/or epicardial.19 However, 
heart symptomatic disease is rare, which is described 
as ischemic syndrome, and is secondary to leukemic 
infiltration of the wall of the coronary arteries,20 
severe endocardial fibroelastosis,19 and constrictive 
pericarditis.21
The classical immunophenotype of CLL is the 
positivity for CD23 (mainly in the pseudofollicles); 
a weak and irregular positivity for B cell markers 
(CD20, CD19 and CD79a); T-cell aberrant expression 
(CD5 and CD43); and the negativity for cyclin D1 
and CD10. The proliferative index tends to be low 
(nearly 5%), but may be higher in the accelerated 
phase of the disease and is associated with treatment 
refractoriness.2 Recently, LEF-1 was described as a 
specific marker for CLL and its expression can be 
accessed by immunohistochemistry, described as 
strong and diffuse in the neoplastic cells, especially 
in cases of Richter transformation.22 The LEF-1 – a 
nuclear mediator of the WNT signaling pathway with 
an important role in lymphopoiesis and expressed in 
pro-B cells – is especially useful in cases without a 
typical immunophenotype, but is not always necessary 
for the diagnosis. In this case, LEF-1 was not performed 
because of its unavailability, but it was considered an 
unnecessary marker for the CLL diagnosis, because 
the immunophenotype and the morphology were 
typical of CLL. In addition, LEF-1-negativity does 
not exclude the diagnosis because its sensitivity and 
specificity is not 100% (it is approximately 70% and 
90%, respectively).23 The immunohistochemical profile 
should always be analyzed in conjunction with the 
morphological aspects for the final diagnosis and 
should differentiate between other small-cell lymphoid 
tumors.2
At  the molecu lar  leve l ,  some karyotype 
abnormalities are observed in about 80% of the 
cases, which include: the gain of chromosome 12 
and the loss of the long arms of chromosomes 13 
(the most common abnormality), 11, 17, and 6. Some 
biological markers associated with worse prognosis 
in the CLL are the expression of ZAP-70 and CD38, 
and the deletion of the short arm of chromosome 
17.1,2,24,25 The case reported herein had the trisomy of 
chromosome 12, but other genetic abnormalities were 
not tested. ZAP-70 was expressed in the neoplastic 
cells and can explain, in part, the poor prognosis. 
However, the advanced stage at the time of diagnosis 
and the difficulties in providing some medications to 
the patient also can be considered as contributors to 
the unfavorable outcome.
Some CLL autopsy series are reported in the 
medical literature. Of note, Möller et al.26 described 
the case of an old man whose CLL transformed to 
Richter’s syndrome and a large retroperitoneal and 
intra-abdominal mass, similar to that observed in our 
patient. However, we did not find the transformation 
to large-cell lymphoma. The large lymph nodes, 
forming large masses, were probably due to advanced 
and refractory disease.
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